Page last updated: 2024-08-24

ranolazine and Ischemic Attack, Transient

ranolazine has been researched along with Ischemic Attack, Transient in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, KP; Ben-Yehuda, O; Dressler, O; Farzaneh-Far, R; Généreux, P; Iñiguez, A; James, S; Ohman, EM; Osmukhina, A; Shechter, M; Stone, GW; Weisz, G; Zurakowski, A	1

Trials

1 trial(s) available for ranolazine and Ischemic Attack, Transient

Article	Year
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2016, Jan-09, Volume: 387, Issue:10014 Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Stenosis; Double-Blind Method; Female; Hospitalization; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Ranolazine; Sodium Channel Blockers; Stroke	2016

Article

Year

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Lancet (London, England), 2016, Jan-09, Volume: 387, Issue:10014

Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Stenosis; Double-Blind Method; Female; Hospitalization; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Ranolazine; Sodium Channel Blockers; Stroke

2016